AksharChem India Limited
AksharChem India Limited (AKSHARCHEM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Dyes And Pigments
aksharchemindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 91 Cr | 97 Cr | 89 Cr | 80 Cr |
| Operating expenses (approx.) | 84 Cr | 91 Cr | 87 Cr | 77 Cr |
| EBITDA | 6 Cr | 6 Cr | 2 Cr | 3 Cr |
| OPM % | 6.9% | 6.6% | 2.6% | 3.7% |
| Other income | -0.09 Cr | 0.04 Cr | 0.03 Cr | 0.05 Cr |
| Interest | 1 Cr | 1 Cr | 1 Cr | 2 Cr |
| Depreciation | 4 Cr | 4 Cr | 4 Cr | 4 Cr |
| Profit before tax | 1 Cr | 1 Cr | -1 Cr | -3 Cr |
| Tax % | -6.9% | 31.1% | 2.5% | -50.4% |
| Net profit | 1 Cr | 0.71 Cr | -1 Cr | -5 Cr |
| EPS (₹) | ₹1.73 | ₹0.89 | ₹-1.70 | ₹-5.75 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 346 Cr | Sign in for TTM |
| Operating expenses (approx.) | 321 Cr | Sign in for TTM |
| EBITDA | 25 Cr | Sign in for TTM |
| OPM % | 7.2% | Sign in for TTM |
| Other income | 0.25 Cr | Sign in for TTM |
| Interest | 5 Cr | Sign in for TTM |
| Depreciation | 14 Cr | Sign in for TTM |
| Profit before tax | 6 Cr | Sign in for TTM |
| Tax % | 18.1% | Sign in for TTM |
| Net profit | 5 Cr | Sign in for TTM |
| EPS (₹) | ₹5.94 | Sign in for TTM |
| Dividend payout % | 10.4% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 8 Cr |
| Reserves | 256 Cr |
| Borrowings | 67 Cr |
| Other liabilities | 85 Cr |
| Total liabilities | 415 Cr |
| Fixed assets (net) | 231 Cr |
| CWIP | 45 Cr |
| Investments | 0.0038 Cr |
| Loans & advances | 0.34 Cr |
| Inventories | 70 Cr |
| Trade receivables | 41 Cr |
| Cash & bank | 0.14 Cr |
| Other assets | 28 Cr |
| Total assets | 415 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | 35 Cr |
| Cash from investing | -44 Cr |
| Cash from financing | 9 Cr |
| Net cash flow | -0.02 Cr |
| Free cash flow (OCF − Capex) | -9 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 3.4% |
| ROE % | 1.8% |
| Debtor days | 43 |
| Inventory days | 138 |
| Days payable | 112 |
| Cash conversion cycle | 68 |
| Debt / equity | 0.25 |
| Current ratio | 1.16 |
| Net debt / EBITDA | 2.68 |
Compare with peers
Loading peers…